Indication
Corneal Endothelial Dystrophy
4 clinical trials
4 products
Product
EO2002Clinical trial
A Phase 1, Prospective, Multi-Center, Open-Label, Dose-Escalation Study to Assess the Safety, and Tolerability of EO2002 With and Without Endothelial Brushing or Descemet Stripping in the Treatment of Corneal Edema (EMME-001)Status: Active (not recruiting), Estimated PCD: 2024-10-30
Product
Loteprednol EtabonateClinical trial
Prospective Analysis of Loteprednol Etabonate Ophthalmic Suspension 0.25% for Prevention of Immunologic Rejection After Descemet Membrane Endothelial KeratoplastyStatus: Completed, Estimated PCD: 2023-09-05
Product
TTHX1114(NM141)Clinical trial
A Phase 1/ Phase 2 Study Evaluating the Safety and Efficacy of the Investigational New Drug TTHX1114(NM141) on the Regeneration of Corneal Endothelial Cells in Patients With Corneal Endothelial Dystrophies Following Intracameral DeliveryStatus: Completed, Estimated PCD: 2021-04-23
Product
TTHX1114Clinical trial
A Phase 2 Clinical Trial to Assess the Safety and Observe the Potential Benefit of TTHX1114 Delivered Via Intra-Cameral (IC) InjectionStatus: Completed, Estimated PCD: 2023-08-29